Sharma Pooja, the Chief Strategy and Marketing Officer at PROCEPT BioRobotics Corp, has sold 4,710 shares of the company’s common stock. This transaction, reported on November 6, 2026, is significant as it illustrates the ongoing adjustments within the company’s management. Such actions can often reflect broader trends in the surgical and medical instruments industry.

PROCEPT BioRobotics Corp, which operates in the surgical and medical instruments and apparatus sector, is known for its innovative technologies. The company is based in San Jose, California, and is publicly traded under the ticker symbol PRCT.

According to the SEC filing, the shares were sold as part of the issuer's sell-to-cover process for tax withholding obligations related to the vesting of restricted stock units on November 5, 2026. Following this transaction, Pooja retains ownership of 106,471 shares.

This sale may affect various stakeholders, including investors and employees, as it highlights the management's financial decisions and their implications for the company's equity structure. The filing does not indicate what happens next for Pooja or the company.

Details of the Transaction

The transaction involved the sale of 4,710 shares of common stock at a price of $19.714 per share, totaling approximately $92,857.94. This sale was executed on November 6, 2026, and was part of a sell-to-cover process for tax withholding obligations arising from the vesting of restricted stock units on November 5, 2026.

Sharma Pooja's position as Chief Strategy and Marketing Officer indicates her significant role within PROCEPT BioRobotics Corp, and her ownership of 106,471 shares following this transaction underscores her continued commitment to the company.

Company Overview

PROCEPT BioRobotics Corp, incorporated in Delaware, operates within the surgical and medical instruments and apparatus sector, classified under the Standard Industrial Classification code 3841. The company is headquartered at 150 Baytech Drive, San Jose, California, and has a fiscal year-end of December 31.

The SEC filing does not provide information on Pooja's future plans regarding her remaining shares or any potential upcoming transactions.